Emblem Corp. (TSX-V:EMC) (EMC.WT), has entered into a licensing agreement with Dosecann Inc. pursuant to which Dosecann will begin developing a range of cannabinoid dosage formulations designed to ensure patients are better able to titrate and administer each dose the exact same way.
MedReleaf Corp. (TSX:LEAF) has announced today that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart.
Premium cannabis lifestyle brand DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) this morning announced its entry into a binding letter of intent setting out the terms pursuant to which it proposes to acquire all of the issued and outstanding shares of Tokyo Smoke.
Backed by mounting scientific data on the curative effects of CBDs, specialty biotech companies like InMed Pharmaceuticals, Inc. (CSE: IN) (OTC: IMLFF) have the opportunity to capitalize on the explosive growth expected in the cannabis-derived pharmaceutical market.
Global Payout, Inc. (OTC: GOHE) announced plans to launch a new subsidiary early next year that will focus on supplying chain finance solutions for the logistics industry.
Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has formalized a letter of intent signed earlier this month related to its entry into a multifaceted joint venture and co-marketing agreement with Smart Cannabis Corp. (OTC: SCNA).
Publicly traded holding company SinglePoint, Inc. (OTC: SING) and its innovative SingleSeed app – designed to allow cannabis dispensaries and customers to exchange funds using debit and credit cards via the vehicle of bitcoin – is singled out in a CNBC article highlighting the industry’s ongoing need for an alternative banking solution (http://cnw.fm/3bA32).
Cryptocurrencies like bitcoin are proving especially valuable as a solution for high-risk industries like cannabis, which remains largely unbanked in the United States due to marijuana’s continued status as a Schedule 1 drug under the Controlled Substances Act.
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has adjourned the voting for proposals three and four from its notice of annual meeting of shareholders, dated October 5, 2017.
The $6.2 billion in weed Canadians consume a year is about two-thirds the $9.2 billion beer market and close to wine’s $7 billion tally
Horizons ETFs Management (Canada) Inc. recently announced completion of its quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF (“HMMJ”).
Within the current multi-billion dollar and rapidly-growing industry (New Frontier Data projects U.S. medical and recreational marijuana sales will reach $24.5 billion by 2025) (http://cnw.fm/A0lmE), REFG is a frontrunner in the booming market that is vying to match growing demand with full spectrum solutions.
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Micron Waste Technologies Inc. ("Micron") (CSE: MWM, OTC: MICWF, Frankfurt: 7FM2), today announced that the companies have signed a non-binding term sheet for Aurora to make a strategic investment in Micron, and for both companies to collaborate on the optimization of Micron's technology for the treatment of organic waste generated in the cultivation and production of cannabis products..
Backed by mounting scientific data on the curative effects of CBDs, specialty biotech companies like InMed Pharmaceuticals, Inc. (CSE: IN) (OTC: IMLFF) have the opportunity to capitalize on the explosive growth expected in the cannabis-derived pharmaceutical market.
InMed's addition to Canada’s Cannabis ETF Could Be Signalling the Start of a Big New Investing Theme = Biotechs.
